- Home
- NVNO
as 03-12-2025 3:41pm EST
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 61.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 104.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1272.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.45 - $6.50 | Next Earning Date: | 05-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 409.09% |
Latest enVVeno Medical Corporation News
NVNO Breaking Stock News: Dive into NVNO Ticker-Specific Updates for Smart Investing
Argus Research
9 hours ago
Daily – Vickers Top Insider Picks for 03/12/2025
Argus Research
a day ago
Daily – Vickers Top Insider Picks for 03/11/2025
Argus Research
2 days ago
Daily – Vickers Top Insider Picks for 03/10/2025
Argus Research
5 days ago
Daily – Vickers Top Insider Picks for 03/07/2025
Argus Research
6 days ago
Daily – Vickers Top Insider Picks for 03/06/2025
Argus Research
7 days ago
Daily – Vickers Top Insider Picks for 03/05/2025
Argus Research
8 days ago
Daily – Vickers Top Insider Picks for 03/04/2025
Argus Research
9 days ago
Daily – Vickers Top Insider Picks for 03/03/2025
Compare NVNO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NVNO enVVeno Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.